NCT05571267 Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD Status TERMINATED Phase PHASE2
NCT04739306 Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT04572698 A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration(wAMD) Status UNKNOWN Phase PHASE3
NCT04058535 Clinical Study of ALT-L9 to Determine Safety, Efficacy and Pharmacokinetics in Neovascular AMD Status COMPLETED Phase PHASE1
NCT03629210 Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema Status WITHDRAWN Phase PHASE2
NCT03610646 Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE3
NCT03374670 ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) Status WITHDRAWN Phase PHASE2
NCT02732899 Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD Status COMPLETED Phase PHASE2
NCT02142296 Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD) Status COMPLETED Phase PHASE4